Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma (CTCL)

Clinical Trial ID NCT01579318

PubWeight™ 3.47‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01579318

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intratumoral immunization: a new paradigm for cancer therapy. Clin Cancer Res 2014 1.24
2 Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother 2014 1.17
3 New insights into IL-12-mediated tumor suppression. Cell Death Differ 2014 1.09
Next 100